2017, Number 6
<< Back Next >>
Acta Ortop Mex 2017; 31 (6)
Comparison of the clinical response to the application of Hylan G-F 20 and collagen-PVP in patients with knee osteoarthritis
Salazar-Guzmán I, Garfias-Rosas J, Butze-Rangel W
Language: Spanish
References: 10
Page: 283-286
PDF size: 162.10 Kb.
ABSTRACT
Background: Knee osteoarthritis is a joint disease characterized by degeneration, loss of cartilage and subchondral bone alteration associated with changes in the soft tissues. In a sample of 2,500 individuals, the prevalence of osteoarthritis was found in 2.3% (IC 95% 1.7 a 2.9) in adults; it represents the second cause of consultation in our hospital.
Material and methods: Two groups of patients were studied: the first included 70 patients who received hylan G-F 20 in three infiltrations; the other group, of 40 patients, received collagen-PVP in four applications. A subjective questionnaire based on the WOMAC evaluation was applied, with which we could assess pain, stiffness and functional capacity before and after the application.
Results: Both hylan G-F 20 and collagen-PVP improved the quality of life of our patients by reducing symptoms such as pain, stiffness and functional limitation, collagen being more efficient for reducing pain and hylan G-F 20 for reducing stiffness and functional limitation.
Conclusions: Both treatments were safe and effective; they can be used in our institute as a conservative treatment to decrease hospitalizations for pain management.
REFERENCES
Bonnet CS, Walsh DA: Osteoarthritis, angiogenesis and inflammation. Rheumatology (Oxford). 2005; 44(1): 7-16.
Peña-Ayala AH, Fernández-López JC: Prevalencia y factores de riesgo de la osteoartritis. Reumatol Clin. 2007; 3 Supl E3: 6-12.
Yang CY, Chanalaris A, Troeberg L: ADAMTS and ADAM metalloproteinases in osteoarthritis e looking beyond the ‘usual suspects’. Osteoarthritis and Cartilage. 2017; 25: 1000-9.
Moreland LW, Arnold WJ, Saway A, Savory C, Sikes D: Efficacy and safety of intraarticular hylan GF-20 (Synvisc), a viscoelastic derivative of hyaluronan, in patients with osteoarthritis of the knee. Arthritis Rheum. 1993; 36: B143.
Leopold SS, Redd BB, Warme WJ, Wehrle PA, Pettis PD, Shott S: Corticosteroid compared with hyaluronic acid injections for the treatment of osteoarthritis of the knee. A prospective, randomized trial. J Bone Joint Surg Am. 2003; 85-A(7): 1197-203.
Guía de práctica clínica para el diagnóstico y tratamiento de la osteoartrosis de rodilla. México: Secretaría de Salud; 2009.
Arango-Pilonieta C: La viscosuplementación y sus efectos en la enfermedad articular. Ortho-tips. 2012; 8(2): 80-6.
Goycochea-Robles MV, López-Roldán VM, Colín-Marín M, Ayala-García MZ, Fragoso-Pedraza MV, Ricardez-Santos G, et al: Guía clínica para la atención de osteoartrosis de rodilla y cadera. Rev Med IMSS. 2003; 41(Supl): S99-107.
López-Alonso SR, Martínez-Sánchez CM, Romero-Cañadillas AB, Navarro-Casado F, González-Rojo J: Metric properties of WOMAC questionnaires —original and reduced versions— to measure symptoms and Physical Functional Disability. Aten Primaria. 2009; 41(11): 613-20.
Furuzawa-Carballeda J, Muñoz-Chablé OA, Macías-Hernández SI, Agualimpia-Janning A: Effect of polymerized-type I collagen in knee osteoarthritis. II. In vivo study. Eur J Clin Invest. 2009; 39(7): 598-606.
Full text